BLADDER CANCER

Brand Owner (click to sort) Address Description
ACCU-DX MENTOR CORPORATION 201 Mentor Drive Santa Barbara CA 93111 rapid one-step gold dye particle lateral flow immunoassay for in vitro qualitative measurement of fibrinogen and fibrin/fibrinogen degradation products (FDP) in human urine to used used with standard cystoscopic examination to aid in the management of patients with a history of bladder cancer; Point of care rapid immunoassays to screen for prostate cancer and for cervical cancer;
MENTOR ACCU-DX MENTOR CORPORATION 201 Mentor Drive Santa Barbara CA 93111 rapid one-step gold dye particle lateral flow immunoassay for in vitro qualitative measurement of fibrinogen and fibrin\fibrinogen degradation products (FDP) in human urine to be used with standard cystoscopic examination to aid in the management of patients with a history of bladder cancer; Point of care rapid immunoassays to screen for prostate cancer and for cervical cancer;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Hepatoma up-regulated protein (HURP) gene serves as a useful molecular marker in the detection, preliminary screening and monitoring of bladder cancer in a human subject. A method for the detection of bladder cancer, in particular transitional cell carcinoma (TCC) of the bladder, in a human subject is disclosed, in which the detected expression of the human HURP gene in a sample taken from a subject suspected to have bladder cancer is indicative of the presence of the bladder cancer. The present invention further provides a non-invasive method for the detection, preliminary screening or monitoring of urinary TCC in a suspected subject, in which a urine sample taken from the subject is analyzed to determine an expression of the human HURP gene, the presence of which is indicative of the presence of urinary TCC.